Mervat N. Saleh

Hematology

18220 State Highway 249 Ste 100
Houston, TX 77070

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer.

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer.

Journal: Contemporary clinical trials communications

Published: January 13, 2018

Showing 1-1 of 1

Last Updated: 09/26/2026